Candel Therapeutics (CADL) Shares Outstanding (Weighted Average) (2020 - 2023)
Historic Shares Outstanding (Weighted Average) for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $28.9 million.
- Candel Therapeutics' Shares Outstanding (Weighted Average) rose 9.66% to $28.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 9.66%. This contributed to the annual value of $28.8 million for FY2022, which is 5272.3% up from last year.
- According to the latest figures from Q3 2023, Candel Therapeutics' Shares Outstanding (Weighted Average) is $28.9 million, which was up 9.66% from $28.9 million recorded in Q2 2023.
- In the past 5 years, Candel Therapeutics' Shares Outstanding (Weighted Average) registered a high of $28.9 million during Q1 2023, and its lowest value of $11.6 million during Q2 2020.
- In the last 4 years, Candel Therapeutics' Shares Outstanding (Weighted Average) had a median value of $26.0 million in 2021 and averaged $21.6 million.
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 14631.72% in 2022, then grew by 9.66% in 2023.
- Quarter analysis of 4 years shows Candel Therapeutics' Shares Outstanding (Weighted Average) stood at $11.6 million in 2020, then skyrocketed by 62.49% to $18.9 million in 2021, then soared by 52.72% to $28.8 million in 2022, then increased by 0.33% to $28.9 million in 2023.
- Its last three reported values are $28.9 million in Q3 2023, $28.9 million for Q2 2023, and $28.9 million during Q1 2023.